Sectra (SECT-B.ST) Stock Analysis & AI Equity Report

Medical - Devices SEK Explore free reports

Sectra (SECT-B.ST) overview

Sectra (SECT-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Sectra reported revenue of SEK 3,542m and operating profit of SEK 663m; the year-end share price was 255.20 SEK and market capitalisation was SEK 49,169m. Sectra is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Sectra's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueSEK 2,138mFY 2025
Share price255.20 SEKFY 2025 year end
RevenueSEK 3,542mFY 2025
Operating profitSEK 663mFY 2025
Net earningsSEK 564mFY 2025
Market capitalisationSEK 49,169mFY 2025 year end

Figures updated on 2026-07-06. Data will be refreshed during report generation.

About Sectra

Sectra AB (publ) develops and sells medical imaging IT and cybersecurity solutions. Its medical systems support healthcare providers with imaging software and related services for diagnostics and workflow efficiency, while its secure communications and security operations offerings help authorities, defense organizations, and other critical functions protect sensitive information and communications.

Generate the Sectra report

Sectra is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Sectra and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.